Company
United StatesAzurity Pharmaceuticals, Inc., Wilmington, MA – FDA Inspections
Inspection records and compliance data for Azurity Pharmaceuticals, Inc. in Wilmington, Massachusetts. 2 FDA inspections on record, 1 warning letter, last inspected November 14, 2024.
Company Profile
This profile covers Azurity Pharmaceuticals, Inc. based in Wilmington, Massachusetts, United States.
FDA Inspection History
- FDA inspections
- 2
- OAI
- 0
- VAI
- 0
- NAI
- 2
- Form 483s
- 0
- Warning letters
- 1
First inspected March 2, 2023. Last inspected November 14, 2024.
FDA inspections (2)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| November 14, 2024 | NAI | Human Drugs · Bioresearch Monitoring | 1255484 |
| March 2, 2023 | NAI | Human Drugs · Drug Quality Assurance | 1200074 |
FDA documents
Warning Letters (1)
Other FDA documents (3)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Lynnfield Drug, Inc. dba Freedom Fertility Pharmacy
Aldeyra Therapeutics, Inc.
New England Compounding Pharmacy, Inc.
Lykos Therapeutics, Inc.
Kohana Pharmacy and Center for Regenerative Medicine Inc.
Davis City Pharmacy Inc.
Mandell's Clinical Pharmacy
East Marietta Drug Company
Xtreme Tools International, Inc.
Cadila Healthcare Limited
Company Information
Name
Azurity Pharmaceuticals, Inc.
FEI Number
3021346595
Address
600 Research Dr, Wilmington, Massachusetts 01887, United States
Country
United States
ID: bc97bdba-f1c1-4152-99eb-962174d79b31